Pharmaniaga Bhd 2024 IR
The report highlights Pharmaniaga Berhad's financial turnaround in 2024, achieving a net profit of RM133.8 million compared to a net loss of RM78.7 million in 2023. The company completed and officiated Malaysia's first local insulin and vaccine manufacturing facility in Puchong, Selangor. Additionally, Pharmaniaga secured a seven-year logistics services concession agreement with the Ministry of Health and obtained approval for its Regularisation Plan from Bursa Malaysia. On the sustainability front, the company achieved a 4-star FTSE4Good ESG rating and launched a solar photovoltaic project across six sites to generate 6,000 MWh of clean energy annually.
Company: Pharmaniaga Bhd
Sector: Health Care
Country: Malaysia
Year: 2024
Type: IR
Pages: 343
Pharmaniaga Bhd
Integrated Report
The report highlights Pharmaniaga Berhad's financial turnaround in 2024, achieving a net profit of RM133.8 million compared to a net loss of RM78.7 million in 2023. The company completed and officiated Malaysia's first local insulin and vaccine manufacturing facility in Puchong, Selangor. Additionally, Pharmaniaga secured a seven-year logistics services concession agreement with the Ministry of Health and obtained approval for its Regularisation Plan from Bursa Malaysia. On the sustainability front, the company achieved a 4-star FTSE4Good ESG rating and launched a solar photovoltaic project across six sites to generate 6,000 MWh of clean energy annually.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Jun 18, 2025
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Net Zero Target
Employees